CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) Peptide
-
- Target See all CEBPB products
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
- Origin
- Human, Cow, Mouse, Pig, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-C/EBP beta Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
- Background
- TCF5, CCAAT/enhancer-binding protein beta, C/EBP beta, Liver activator protein, LAP, Liver-enriched inhibitory protein, LIP, Nuclear factor NF-IL6, Transcription factor 5, TCF-5
- Gene ID
- 1051, 12608, 24253
- UniProt
- P17676, P28033, P21272
-